SEC Form 4 · accession 0001140361-16-086279
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 11, 2016
Accepted (ET)
Nov 14, 2016 · 2:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Nov 11, 2016 | F | 1,043 | $59.85 | D | 81,273 | D | |
| ResMed Common StockF2 | Nov 11, 2016 | F | 1,194 | $59.85 | D | 79,036 | D | |
| ResMed Common StockF3 | Nov 11, 2016 | F | 1,140 | $59.85 | D | 77,896 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/13/2013.
- F2Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
- F3Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.